No Impact of Long-Term Fingolimod Treatment on Fecal Secretory Immunoglobulin A Levels in Patients With Multiple Sclerosis

• Hernan Inojosa,
• Judith Eisele,
• Undine Proschmann,
• Sebastian Zeissig,
• Katja Akgün,
• Tjalf Ziemssen

Affiliations

Hernan Inojosa

Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

Judith Eisele

Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

Undine Proschmann

Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

Sebastian Zeissig

Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

Katja Akgün

Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

Tjalf Ziemssen

Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany